The Enterprise Value as of December 2025 (TTM) for Invizyne Technologies Inc. Common Stock (IZTC) is 99.07M

According to Invizyne Technologies Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 99.07M. This represents a change of -0.97% compared to the average of 100.03M of the last 4 quarters.

Invizyne Technologies Inc. Common Stock (IZTC) Historical Enterprise Value (quarterly & annually)

How has IZTC Enterprise Value performed in the past?

The mean historical Enterprise Value of Invizyne Technologies Inc. Common Stock over the last ten years is 84.61M. The current 99.07M Enterprise Value has changed 11.61% with respect to the historical average. Over the past ten years (40 quarters), IZTC's Enterprise Value was at its highest in in the December 2024 quarter at 125.77M. The Enterprise Value was at its lowest in in the March 2023 quarter at 0.

Invizyne Technologies Inc. Common Stock (IZTC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Invizyne Technologies Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Invizyne Technologies Inc. Common Stock (IZTC) Average Enterprise Value

How has IZTC Enterprise Value performed in the past?

The current Enterprise Value of Invizyne Technologies Inc. Common Stock (IZTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Invizyne Technologies Inc. Common Stock (IZTC) Enterprise Value vs. Peers

How is IZTC’s Enterprise Value compared to its peers?

Invizyne Technologies Inc. Common Stock’s Enterprise Value is greater than F-star Therapeutics, Inc. (91.20M), greater than Pardes Biosciences, Inc. (75.90M), greater than Selecta Biosciences, Inc. (-11774246.00), greater than Quoin Pharmaceuticals, Ltd. (6.68M), greater than Theseus Pharmaceuticals, Inc. (90.87M), less than Theratechnologies Inc. (183.14M), greater than aTyr Pharma, Inc. (79.70M), less than Sesen Bio, Inc. (127.66M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than LENZ Therapeutics, Inc. (465.84M),

Build a custom stock screener for Invizyne Technologies Inc. Common Stock (IZTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invizyne Technologies Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Invizyne Technologies Inc. Common Stock (IZTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Invizyne Technologies Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.